Jun 29, 2022
In this week’s View, Dr. Eagle discusses the newly published table that lists drug-drug interactions with the anti-viral agent Paxlovid, used in treating COVID-19, then looks at an analysis of the LIFE Trial Run-In that examines the tolerability of sacubitril/valsartan in patients with advanced heart failure. Finally,...
Jun 22, 2022
In this week’s View, Dr. Eagle discusses rivaroxaban monotherapy vs combination therapy with antiplatelets on total thrombotic and bleeding events in atrial fibrillation with stable coronary artery disease, then looks at pre-operative atrial fibrillation and cardiovascular outcomes after non-cardiac surgery. Finally,...
Jun 15, 2022
In this week’s View, Dr. Eagle discusses a prospective evaluation of cardiovascular risk ten years after a hypertensive disorder of pregnancy, then looks at the effect of varenicline added to counseling on smoking cessation among African American daily smokers. Finally, Dr. Eagle explores Dr. Nanette Wenger’s Call...
Jun 8, 2022
In this week’s View, Dr. Eagle discusses the association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality, then looks at the association of sedentary time and physical activity with the risk of stroke among US adults. Finally, Dr. Eagle explores...
Jun 1, 2022
In this week’s View, Dr. Eagle discusses nighttime masked uncontrolled hypertension among patients with chronic kidney disease, then looks at the characteristics and natural history of early-stage cardiac transthyretin amyloidosis. Finally, Dr. Eagle explores the incidence of ischemic stroke in patients...